Health Trials

Refractory B Acute Lymphoblastic Leukaemia

1

Review clinical trials related to Refractory B Acute Lymphoblastic Leukaemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL

This is Phase II / III, Prospective, single arm, Open Label Study to Evaluate Safety and Efficacy of Intravenous Autologous CD19 CAR-T Cells for Relapsed / Refractory B-Acute Lymphoblastic Leukaemia

Participants needed: 10
Trial details
Phase: Phase 2, Phase 3Age: 13-65Biological sex: AllType: InterventionalSponsor: National University of MalaysiaUpdated: May 29, 2025Locations: 1
Eligibility criteria

Patients with relapsed/refractory B-ALL in accordance with World Health Organiza... [+9]

Patients with CNS-3 leukaemia. [+9]

Read more